Many more people with HIV are now surviving for longer, thanks to new antiretroviral drug treatments. But their governments must now come up with a way to pay for their ongoing treatment. But the price is putting many countries in sub-Saharan Africa at risk of unsustainable levels of debt.

By Sir Paul Collier, Professor of Economics and Public Policy in the Blavatnik School of Government, University of Oxford